Literature DB >> 6174540

Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon.

R B Herberman, J R Ortaldo, M Rubinstein, S Pestka.   

Abstract

Augmentation of the cytolytic activity of human natural killer cells and of antibody-dependent cell-mediated cytotoxicity has been attributed to human interferons. With the purification to homogeneity of human leukocyte interferon, it became possible to test directly whether pure interferon could increase the activity of these effector cells. Treatment of purified blood mononuclear cells with pure interferon resulted in substantial increases in natural killer cell activity and in antibody-dependent cell-mediated cytotoxicity. Concentrations of 10-100 units/ml of antiviral activity were sufficient to augment appreciably natural killer cell activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6174540     DOI: 10.1007/BF00922756

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

1.  Cytolytic and cytostatic activity on tumor cells of circulating human monocytes.

Authors:  A Mantovani; T R Jerrells; J H Dean; R B Herberman
Journal:  Int J Cancer       Date:  1979-01-15       Impact factor: 7.396

2.  Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.

Authors:  T C Merigan; K Sikora; J H Breeden; R Levy; S A Rosenberg
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

Review 3.  Interferons: anti-neoplastic drugs?

Authors:  H Strander
Journal:  Blut       Date:  1977-09-18

4.  Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes.

Authors:  P Lindahl; P Leary; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

5.  Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins.

Authors:  G Trinchieri; D Santoli; H Koprowski
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Human leukocyte interferon: production, purification to homogeneity, and initial characterization.

Authors:  M Rubinstein; S Rubinstein; P C Familletti; R S Miller; A A Waldman; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

7.  Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells.

Authors:  P Lindahl; P Leary; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

8.  Human leukocyte interferon produced by E. coli is biologically active.

Authors:  D V Goeddel; E Yelverton; A Ullrich; H L Heyneker; G Miozzari; W Holmes; P H Seeburg; T Dull; L May; N Stebbing; R Crea; S Maeda; R McCandliss; A Sloma; J M Tabor; M Gross; P C Familletti; S Pestka
Journal:  Nature       Date:  1980-10-02       Impact factor: 49.962

9.  Regulatory effect of interferon on T cells in vitro.

Authors:  I Heron; K Berg; K Cantell
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

10.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Antitumour actions of interferons: implications for cancer therapy.

Authors:  Belinda S Parker; Jai Rautela; Paul J Hertzog
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

2.  Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives.

Authors:  S Sone; G Lopez-Berestein; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Biosynthetic human interferon treatment of herpetic keratitis.

Authors:  G Smolin
Journal:  Trans Am Ophthalmol Soc       Date:  1983

4.  Antibody-dependent cell-mediated cytotoxicity. Effectors, signals, and mechanisms.

Authors:  E W Fuson; R A Hubbard; D G Sugantharaj; R B Andrews; M R Beard; R L Whittaker
Journal:  Surv Immunol Res       Date:  1983

5.  Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2.

Authors:  G A Limb; A Meager; J Woolley; M Wadhwa; J Biggerstaff; K A Brown; R A Wolstencroft
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

6.  The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon gamma.

Authors:  I Doelker; F A Anderer
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

7.  Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis.

Authors:  J Hauer; F A Anderer
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

8.  Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.

Authors:  M R O'Gorman; J Oger; L F Kastrukoff
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

9.  Natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities can be differentiated by their different sensitivities to interferon and prostaglandin E1.

Authors:  J E Merrill
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.